Related Experiment Video

Updated: May 15, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Metastatic gastric cancer treatment: a little slow but worthy progress

Ozkan Kanat1, Bert H O'Neil

  • 1Faculty of Medicine, Department of Medical Oncology, Uludag University, Bursa, Turkey. ozkanat@uludag.edu.tr

Medical Oncology (Northwood, London, England)
|January 22, 2013
PubMed

Insights

Metastatic gastric cancer is a leading cause of cancer death. Newer chemotherapy and targeted agents offer improved outcomes for patients with this incurable disease.

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Metastatic gastric cancer is incurable and a major global cause of cancer mortality.
  • Despite advances, it presents significant therapeutic challenges for oncologists.

Purpose of the Study:

  • To review the current treatment strategies for metastatic gastric cancer.
  • To highlight recent advancements in systemic therapy.

Main Methods:

  • Literature review of current treatment approaches.
  • Analysis of systemic treatment options including chemotherapy and targeted agents.

Main Results:

  • Newer chemotherapy regimens show promise in improving patient outcomes.
  • Addition of molecularly targeted agents to chemotherapy enhances clinical results.

Conclusions:

  • Current treatment focuses on systemic therapies to improve outcomes for metastatic gastric cancer.
  • Combination of chemotherapy and targeted agents represents a key advancement.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...